400+
Over 400 real-world studies utilizing real-world data published through Ontada.
Oncology & Multispecialty Solutions
Connecting What Makes Specialty Care Possible
People living with cancer and other complex conditions rely on coordinated care to access treatment. At the same time, biopharma innovation is advancing rapidly, bringing forward new therapies that depend on seamless collaboration to reach patients.
As a leading oncology and specialty distributor, McKesson connects patients, providers and biopharma partners through an integrated ecosystem of services across the drug lifecycle. Our role is to help ensure lifesaving therapies reach the people who need them efficiently, reliably and closer to home.
Our Oncology & Multispecialty solutions reduce barriers across the care journey. We help accelerate drug development and clinical trial activation, expand access to high‑quality care in local communities, and generate real‑world evidence to support better decisions and outcomes. Together, these efforts turn complexity into coordinated action, advancing care with clarity and purpose.
Oncology & Multispecialty at a Glance
For nearly 20 years, we have invested deeply in oncology and specialty services and technology solutions, working behind the scenes to support provider independence so patients can receive high‑quality care close to home.
2.0M+
Over 2 million cancer patients are supported through The US Oncology Network.
$5.5B
$5.5 billion in savings delivered through our group purchasing organizations (GPOs).
700+
Over 700 clinical trials are actively enrolling, with approximately 3,500 patients participating in treatment studies each year through SCRI.
Our Oncology & Multispecialty Businesses
We have created a platform that supports providers and their patients at every stage of the patient journey from diagnosis to treatment planning to care delivery.
Advancing oncology through clinical care and research
The US Oncology Network
The US Oncology Network supports independent oncology providers and their patients by reducing administrative burden, enabling independence and helping practices thrive in a rapidly evolving healthcare landscape.
Ontada
Ontada provides responsibly governed real-world data, research and provider education to accelerate drug development, inform market strategies, and improve health outcomes.
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) partners with biopharma companies to advance the science of cancer treatments.
McKesson Compile
McKesson Compile provides longitudinal patient‑journey data and analytics that help biopharma companies develop and commercialize therapies using real‑world insights.
Improving therapy, access and patient outcomes
Biologics by McKesson
Biologics by McKesson specialty pharmacy services simplifies access to therapies and delivers personalized, high-touch support for cancer, cell and gene and rare disease patients.
McKesson Group Purchasing Organization Strategies
Our Group Purchasing Organization Strategies help practices lower their drug costs and support access to advanced therapies.
Genospace
Genospace advances precision medicine by enabling clinical trial matching in community practices.
Specialty Practice Solutions
Our Specialty Practice Solutions help providers run successful businesses by clearing the path so they can focus on patient care.
InspiroGene by McKesson
InspiroGene delivers complex cell and gene therapies directly to patients and providers, advancing innovative treatment delivery.
Intrafusion by McKesson
Intrafusion by McKesson offers infusion management services to help multispecialty practices simplify and optimize infusion operations.
McKesson Clinical Research Services and Clinical Trial Solutions
Our Clinical Research Services and Clinical Trial Solutions support the commercialization of medications by simplifying clinical trial logistics.
CoverMyMeds
CoverMyMeds streamlines the entire therapy journey by connecting services like electronic prior authorization, benefits verification, affordability support and other support services, making it easier for patients to start treatment and stay on it.
PRISM Vision Group®
PRISM Vision Group is a business and administrative services organization that provides supporting services to U.S. ophthalmology and retina practices and surgery centers.
Who We Serve
We support life sciences companies and care providers across the healthcare spectrum.
Life Sciences Companies
- Biopharma
- Biotech
- Biomedical
- Pharmaceuticals
Healthcare Settings
- Health Systems
- Independent Community Practices
- Specialty Pharmacies
Specialty Practices
- Oncology
- Retina
- Rheumatology
- Gastroenterology
- Neurology
Advancing Community Oncology Report
According to McKesson’s Advancing Community Oncology Report (2025), community oncologists and administrators found administrative burdens topped the list of challenges practices face.
See how collaboration between biopharma and community oncology is transforming patient care, driving innovation and shaping the future of cancer treatment.
Advancing Cancer Care
Today, one in two men and one in three women will be diagnosed with cancer during their lifetime. That’s why together with our partners, we offer research, insights, technologies and services that assist providers and biopharma companies in navigating the intricacies of advancing cancer care.
Accelerating Care Through Our Oncology Ecosystem
Advancing Specialty Access
Advancing Cell and Gene Therapy
Advancing Precision and Personalized Medicine
The True Meaning of Partnership
Pharmaceutical Distribution Services
As the #1 distributor of oncology, rheumatology and gastroenterology products, we offer the expertise to manage through logistical challenges like cold chain requirements, regulatory compliance, dispensing support and more.
Stories
Explore Our Oncology & Multispecialty Stories and Insights
Discover our oncology and multispecialty stories, from business insights to employee spotlights and more.
How the Intelligent Medical Record Could Help Community Oncology
Cracking the Cost-Density Code
Linked Oncology Data is Becoming a Biopharma Priority
Supporting Community-based Ophthalmology Providers
What Real-World Data Shows About GLP-1 Therapies and Survival in Cancer Research
Improving Patient Access Through Community Oncology
Contact Oncology & Multispecialty Solutions
Connect with our team to explore solutions that help improve access, accelerate innovation and support better patient outcomes.